Also, injection of DCs pulsed with ApoB-100-derived peptides and IL-10 to induce a tolerogenic phenotype in human ApoB-100-transgenic Ldlr−/− mice has led to diminished atherosclerosis, as well as attenuated systemic and local inflammatory responses [91]. The gene discussed is LDLR; the disease is atherosclerosis.